MINISTER OF THE STATE IN THE MINISTRY OF HEALTH & FAMILY WELFARE (SHRI GHULAM NABI AZAD)
(a) & (b): The office of Drug Controller General (India) [DCG(I)] had written on 18.07.2007 to the Port and Zonal
offices of Central Drugs Standard Control Organisation (CDSCO) not to send the samples of Diagnostic kits and
blood products to National Institute of Biologicals (NIB) for test till further orders. The Zonal Offices were,
however, permitted to send samples for tests to NIB from 10.02.2009.
(c) to (e): The following samples were received by NIB from CDSCO (West Zone) between July, 2007 to February, 2009:
(i) Blood products:
(1) Reliance Life Sciences, Mumbai (274)
(2) Celestial Biologicals Ltd., Ahmedabad (14)
(3) Bharat Serums & Vaccines, Mumbai (2)
(ii) Diagnostic Kits: 3 kits were received from Span Diagnostics, Surat.
The DCG(I) has informed that the samples were forwarded because of the condition of the license issued under Drugs
and Cosmetics Rules, 1945 to the manufacturer to send the samples to NIB for testing. Disciplinary proceedings had
been taken against the then Director (NIB) for the alleged irregularities which took place in the Institute during
his tenure. He was also repatriated to his parent office.